Literature DB >> 10471588

Bactericidal/permeability-increasing protein inhibits growth of a strain of Acholeplasma laidlawii and L forms of the gram-positive bacteria Staphylococcus aureus and Streptococcus pyogenes.

A H Horwitz1, R E Williams, P S Liu, R Nadell.   

Abstract

Bactericidal/permeability-increasing protein (BPI) inhibited growth of cell wall-deficient Acholeplasma laidlawii and L forms of certain strains of Staphylococcus aureus and Streptococcus pyogenes. However, the same strains of S. aureus and S. pyogenes with intact cell walls were not susceptible to the growth-inhibitory effects of BPI.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10471588      PMCID： PMC89470     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  7 in total

1.  Separation of sublethal and lethal effects of the bactericidal/permeability increasing protein on Escherichia coli.

Authors:  B A Mannion; J Weiss; P Elsbach
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

2.  Expression and characterization of cysteine-modified variants of an amino-terminal fragment of bactericidal/permeability-increasing protein.

Authors:  A H Horwitz; S D Leigh; S Abrahamson; H Gazzano-Santoro; P S Liu; R E Williams; S F Carroll; G Theofan
Journal:  Protein Expr Purif       Date:  1996-08       Impact factor: 1.650

3.  Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria.

Authors:  J Weiss; P Elsbach; C Shu; J Castillo; L Grinna; A Horwitz; G Theofan
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

Review 4.  The bactericidal/permeability-increasing protein (BPI), a potent element in host-defense against gram-negative bacteria and lipopolysaccharide.

Authors:  P Elsbach; J Weiss
Journal:  Immunobiology       Date:  1993-04       Impact factor: 3.144

5.  High-affinity binding of the bactericidal/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide.

Authors:  H Gazzano-Santoro; J B Parent; L Grinna; A Horwitz; T Parsons; G Theofan; P Elsbach; J Weiss; P J Conlon
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

6.  Effects of the bactericidal/permeability-increasing protein of polymorphonuclear leukocytes on isolated bacterial cytoplasmic membrane vesicles.

Authors:  G in't Veld; B Mannion; J Weiss; P Elsbach
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

7.  Human lipopolysaccharide-binding protein potentiates bactericidal activity of human bactericidal/permeability-increasing protein.

Authors:  A H Horwitz; R E Williams; G Nowakowski
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441
  7 in total
  7 in total

Review 1.  Review article: ageing and the neutrophil: no appetite for killing?

Authors:  S Butcher; H Chahel; J M Lord
Journal:  Immunology       Date:  2000-08       Impact factor: 7.397

2.  Hypertonic saline enhances host response to bacterial challenge by augmenting receptor-independent neutrophil intracellular superoxide formation.

Authors:  Conor J Shields; Adrian W O'Sullivan; Jiang H Wang; Desmond C Winter; William O Kirwan; H Paul Redmond
Journal:  Ann Surg       Date:  2003-08       Impact factor: 12.969

3.  Proteomic analysis of pure human airway gland mucus reveals a large component of protective proteins.

Authors:  Nam Soo Joo; Idil Apak T Evans; Hyung-Ju Cho; Il-Ho Park; John F Engelhardt; Jeffrey J Wine
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

4.  Ovocalyxin-36 is a pattern recognition protein in chicken eggshell membranes.

Authors:  Cristianne M M Cordeiro; Hamed Esmaili; George Ansah; Maxwell T Hincke
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

5.  Recombinant human plasma phospholipid transfer protein (PLTP) to prevent bacterial growth and to treat sepsis.

Authors:  Valérie Deckert; Stéphanie Lemaire; Pierre-Jean Ripoll; Jean-Paul Pais de Barros; Jérôme Labbé; Caroline Chabert-Le Borgne; Véronique Turquois; Guillaume Maquart; Delphine Larose; Nicolas Desroche; Franck Ménétrier; Naig Le Guern; Lorène J Lebrun; Catherine Desrumaux; Thomas Gautier; Jacques Grober; Charles Thomas; David Masson; Louis-Marie Houdebine; Laurent Lagrost
Journal:  Sci Rep       Date:  2017-06-08       Impact factor: 4.379

Review 6.  Killing three birds with one BPI: Bactericidal, opsonic, and anti-inflammatory functions.

Authors:  Jomkuan Theprungsirikul; Sladjana Skopelja-Gardner; William F C Rigby
Journal:  J Transl Autoimmun       Date:  2021-05-28

7.  Pilot experience with opebacan/rBPI 21 in myeloablative hematopoietic cell transplantation.

Authors:  Eva Guinan; David E Avigan; Robert J Soiffer; Nancy J Bunin; Lisa L Brennan; Ilana Bergelson; Spencer Brightman; Al Ozonoff; Patrick J Scannon; Ofer Levy
Journal:  F1000Res       Date:  2015-12-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.